Analysis of Clinical Outcomes in Patients Undergoing Acute Dialysis Therapy at Intensive Care Units
1 other identifier
observational
300
1 country
1
Brief Summary
Acute kidney injury is more frequent and the mortality rate would be as high as 50-60% when the renal replacement therapy was needed. Many studies about the timing of start and discontinuation of dialysis, dialysis dose, dialyzer, anticoagulation and dialysates were initiated but the results were still controversial. In addition, more new biomarkers were found to predict the outcome of acute kidney injury and these biomarkers may play an important role for the dilemma of aforementioned studies. This observational prospective study has two objectives:
- 1.To find the predictors of outcome for the acute kidney injury with renal replacement therapy and determine the appropriate method.
- 2.To find the relationship between new biomarkers and acute kidney injury and determine whether it can be a factor for the monitor of the response of the renal replacement therapy.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Jan 2010
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
December 24, 2009
CompletedFirst Posted
Study publicly available on registry
December 25, 2009
CompletedStudy Start
First participant enrolled
January 1, 2010
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 1, 2011
CompletedStudy Completion
Last participant's last visit for all outcomes
July 1, 2011
CompletedJanuary 29, 2010
January 1, 2010
1.4 years
December 24, 2009
January 28, 2010
Conditions
Keywords
Eligibility Criteria
Patients older than 18 years-old and admitted to intensive care units of National Taiwan University Hospital
You may qualify if:
- Patients older than 18 years-old and admitted to intensive care units of National Taiwan University Hospital
You may not qualify if:
- End stage renal disease
- Terminal disease with estimated life span shorter than 28 days
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
National Taiwan University Hospital
Taipei, 10002, Taiwan
Biospecimen
Collect serum and urine sample for biomarkers at the following timing: start date of renal replacement therapy, discontinuation date of renal replacement therapy, 7 days after discontinuation date of renal replacement therapy. 10ml blood and 10ml urine will be collected at each sampling
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
Study Record Dates
First Submitted
December 24, 2009
First Posted
December 25, 2009
Study Start
January 1, 2010
Primary Completion
June 1, 2011
Study Completion
July 1, 2011
Last Updated
January 29, 2010
Record last verified: 2010-01